| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |